<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02930733</url>
  </required_header>
  <id_info>
    <org_study_id>AUTF ANESTHESIA3</org_study_id>
    <nct_id>NCT02930733</nct_id>
  </id_info>
  <brief_title>Serratus Plane Block For Breast Reduction Surgery</brief_title>
  <acronym>SPB</acronym>
  <official_title>The Effects of Bilateral Serratus Plane Block on Postoperative Opioid Consumption After Breast Reduction Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ataturk University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ataturk University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Serratus plane block was first described in 2013 by Blanco and designed to primarily block
      the thoracic intercostal nerves. And this block provides sufficient analgesia lateral
      anterior and posterior part of thoracic wall.Increased use of ultrasound guidance for
      regional anesthesia in recent years has led to definition of thoracic wall PECs blocks by
      Blanco. The Serratus plain block (SPB), providing wider analgesia, with easier application
      and less adverse effects than neuroaxial blocks, has been defined after these blocks and has
      taken its place in the literature.In spite of the insufficient randomized clinical trials in
      the literature, SPB has been reported for many cases such as thoracoscopy, shoulder
      arthroscopy, breast surgery and axillary lymph node dissections, and the results are
      promising. The aim of this study is to determine effectiveness of ultrasound guided bilateral
      serratus plane block in patients undergoing breast reduction surgery.

      Main outcome measures: The primary endpoint is postoperative opioid consumption.

      Secondary endpoints are visual analogue pain scores, opioid related side effects.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Opioid Consumption</measure>
    <time_frame>First 24 hours total opioid consumption</time_frame>
    <description>First 24 hours total fentanyl consumption with patient controlled analgesia</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual analog pain score</measure>
    <time_frame>postoperative first hour</time_frame>
    <description>Post operative pain will be evaluated with a Visual Analogue Scale (VAS) score of 0-10 (0= no pain and 10= worst imaginable pain) at first hour postoperatively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual analog pain score</measure>
    <time_frame>postoperative second hour</time_frame>
    <description>Post operative pain will be evaluated with a Visual Analogue Scale (VAS) score of 0-10 (0= no pain and 10= worst imaginable pain) at second hour postoperatively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual analog pain score</measure>
    <time_frame>postoperative 4th hour</time_frame>
    <description>Post operative pain will be evaluated with a Visual Analogue Scale (VAS) score of 0-10 (0= no pain and 10= worst imaginable pain) at 4th hour postoperatively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual analog pain score</measure>
    <time_frame>postoperative 8thhour</time_frame>
    <description>Post operative pain will be evaluated with a Visual Analogue Scale (VAS) score of 0-10 (0= no pain and 10= worst imaginable pain) at 8th hour postoperatively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual analog pain score</measure>
    <time_frame>postoperative 12th hour</time_frame>
    <description>Post operative pain will be evaluated with a Visual Analogue Scale (VAS) score of 0-10 (0= no pain and 10= worst imaginable pain) at 12th hour postoperatively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual analog pain score</measure>
    <time_frame>postoperative 24th hour</time_frame>
    <description>Post operative pain will be evaluated with a Visual Analogue Scale (VAS) score of 0-10 (0= no pain and 10= worst imaginable pain) at 24th hour postoperatively.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Pain Management</condition>
  <arm_group>
    <arm_group_label>ultrasound guided serratus plane block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bilateral ultrasound guided serratus plane block with 30 ml %0,25 bupivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ultrasound guided sham block</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Bilateral ultrasound guided sham block with 2 ml saline subcutaneously</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>30 ml %0,25 bupivacaine bilaterally</description>
    <arm_group_label>ultrasound guided serratus plane block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>2 ml saline subcutaneously bilaterally</description>
    <arm_group_label>ultrasound guided sham block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologist's physiologic state I-III patients undergoing
             breast reduction surgery

        Exclusion Criteria:

          -  chronic pain

          -  bleeding disorders

          -  renal or hepatic insufficiency

          -  patients on chronic non-steroidal anti-inflammatory medications

          -  emergency cases
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ali Ahiskalioglu</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ataturk University Anesthesiology and Reanimation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ataturk University</name>
      <address>
        <city>Erzurum</city>
        <zip>25100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Blanco R, Parras T, McDonnell JG, Prats-Galino A. Serratus plane block: a novel ultrasound-guided thoracic wall nerve block. Anaesthesia. 2013 Nov;68(11):1107-13. doi: 10.1111/anae.12344. Epub 2013 Aug 7.</citation>
    <PMID>23923989</PMID>
  </reference>
  <reference>
    <citation>Broseta AM, Errando C, De Andrés J, Díaz-Cambronero O, Ortega-Monzó J. Serratus plane block: the regional analgesia technique for thoracoscopy? Anaesthesia. 2015 Nov;70(11):1329-30. doi: 10.1111/anae.13263.</citation>
    <PMID>26449303</PMID>
  </reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 10, 2016</study_first_submitted>
  <study_first_submitted_qc>October 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 12, 2016</study_first_posted>
  <last_update_submitted>January 21, 2017</last_update_submitted>
  <last_update_submitted_qc>January 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ataturk University</investigator_affiliation>
    <investigator_full_name>Ali Ahiskalioglu</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Postoperative Analgesia</keyword>
  <keyword>Ultrasound guided serratus plane block</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

